Nova Biomedical

Nova Biomedical is pleased to announce the launch of BioProfile FAST CDV, a high-throughput, fully automated viable cell density and viability analyzer capable of producing results in under 70 seconds with just 100μL of sample volume.

The U.S. Food and Drug Administration (FDA) has cleared Nova Primary as a blood glucose reference analyzer.

Nova Biomedical announces the launch of the Nova Max Pro Creatinine/eGFR Meter System in all CE countries.

In a 670-patient study funded by the International Society of Nephrology, the South Africa Medical Research Council, and the University of Witwatersrand, Johannesburg, South Africa, the Nova POC StatSensor Creatinine/eGFR meter was more accurate than the.

Nova Biomedical is pleased to announce the opening of a new sales, service, and distribution subsidiary in Benelux.

Nova Biomedical announces the addition of a Sample Retain Collector (SRC) for BioProfile FLEX2 cell culture analyzer.

Nova Biomedical announces the availability of Nova Primary, a rapid, accurate, easy to use, blood glucose laboratory analyzer.

Nova Biomedical announces the addition of C-reactive protein (CRP) testing to its Allegro capillary blood analyzer for point-of-care (POC) testing in primary care settings.

Risk of Ascorbic Acid and Hematocrit Interference That Can Elevate Glucose Meter Results

Simple, fast, and accurate ambulance and emergency blood testing